Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin. (Q50718662)
Jump to navigation
Jump to search
scientific article published in May 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin. |
scientific article published in May 2003 |
Statements
1 reference
Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin. (English)
1 reference
Eeva Piitulainen
1 reference
Elisabeth Bernspång
1 reference
Sven Björkman
1 reference
Erik Berntorp
1 reference
1 May 2003
1 reference
59
1 reference
151-156
1 reference
2
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference